Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

The drug daraxonrasib could be a potential new treatment to double the survival of advanced pancreatic cancer patients, a groundbreaking new clinical trial suggests. Pancreatic cancer patients often ...

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 ...

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to ...

Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research ...

An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated ...

Pancreatic cancer is one of the deadliest diagnoses. American Cancer Society data shows only about 13% of patients live five ...

For the first time in the world, Radboudumc has treated a patient with pancreatic cancer using a new experimental ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

An experimental drug, daraxonrasib from Revolution Medicines, nearly doubles survival time for pancreatic cancer patients in ...